Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

The New York Times - Business:

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.

Author: Rebecca Robbins

This post first appeared in The New York Times - Business. Read the original article.